Table 3.
Means, Differences, Effect Sizes, and 95% Confidence Intervals (CI) on Study Measures for Survivors
| Survivors (N=28) | ||||
|---|---|---|---|---|
| IE (N=19) |
LHT (N=9) |
Difference‡ | Effect Size | |
| Mean (95% CI) |
Mean (95% CI) |
Mean (95% CI) |
Effect Size (95% CI) |
|
| Sexual Outcomes | ||||
| Sexual Function – Female (FSFI) | -- | -- | 10.14 (3.37, 16.90) | 1.24 (0.37, 2.18) |
| Baseline | 14.26 (9.23, 19.30) | 20.02 (12.45, 27.60) | -- | -- |
| Follow-up | 24.02 (19.80, 28.24) | 19.64 (10.99, 28.29) | -- | -- |
| Sexual Satisfaction (PROMIS SexFS) | -- | -- | 10.14 (5.45, 14.82) | 1.75 (0.83, 2.77) |
| Baseline | 41.08 (37.26, 44.90) | 44.98 (38.62, 51.34) | -- | -- |
| Follow-up | 48.46 (45.36, 51.56) | 42.22 (36.72, 47.72) | -- | -- |
| Sexual Distress (FSDS-R) | -- | -- | −7.77 (−15.10, −0.44) | −0.87 (−1.77, −0.03) |
| Baseline | 25.16 (18.52, 31.80) | 28.22 (17.15, 39.29) | -- | -- |
| Follow-up | 15.95 (10.49, 21.41) | 26.78 (16.29, 37.27) | -- | -- |
| Self-Efficacy | -- | -- | 24.72 (8.05, 41.38) | 1.21 (0.34, 2.14) |
| Baseline | 58.25 (45.76, 70.73) | 60.00 (39.83, 80.18) | -- | -- |
| Follow-up | 83.33 (77.44, 89.22) | 60.37 (42.74, 78.00) | -- | -- |
| Relationship Outcomes | ||||
| Sexual Communication (DSCS) | -- | -- | 9.14 (−1.68, 19.97) | 0.71 (−0.12, 1.59) |
| Baseline | 53.50 (47.73, 59.28) | 57.22 (47.94, 66.50) | -- | -- |
| Follow-up | 62.32 (58.07, 66.56) | 56.89 (49.15, 64.63) | -- | -- |
| Emotional Intimacy (PAIR) | -- | -- | 0.03 (−0.51, 0.57) | 0.04 (−0.79, 0.88) |
| Baseline | 3.56 (3.20, 3.92) | 3.74 (3.10, 4.38) | -- | -- |
| Follow-up | 3.87 (3.55, 4.18) | 4.02 (3.74, 4.29) | -- | -- |
| Relationship Quality (DAS-7) | -- | -- | −1.65 (−6.13, 2.83) | −0.32 (−1.17, 0.50) |
| Baseline | 24.53 (21.94, 27.11) | 25.67 (19.80, 31.53) | -- | -- |
| Follow-up | 25.21 (23.19, 27.23) | 28.00 (24.72, 31.28) | -- | -- |
| Psychosocial Outcomes | ||||
| Body Image Distress (BIS) | -- | -- | −0.85 (−5.29, 3.58) | −0.17 (−1.00, 0.66) |
| Baseline | 10.05 (6.35, 13.76) | 11.00 (4.49, 17.51) | -- | -- |
| Follow-up | 7.42 (4.06, 10.78) | 9.22 (3.58, 14.87) | -- | -- |
| Cancer-related Distress (IES-R) | -- | -- | −3.65 (−11.76, 4.46) | −0.37 (−1.22, 0.46) |
| Baseline | 17.00 (9.22, 24.78) | 16.00 (8.72, 23.28) | -- | |
| Follow-up | 11.68 (5.41, 17.96) | 14.33 (5.69, 22.98) | -- | |
| Depressive Symptoms (PHQ-9) | -- | -- | −1.95 (−4.36, 0.46) | −0.66 (−1.54, 0.17) |
| Baseline | 5.58 (2.85, 8.31) | 5.11 (1.11, 9.11) | -- | |
| Follow-up | 3.63 (1.71, 5.55) | 5.11 (1.26, 8.96) | -- | |
| Anxiety Symptoms (GAD-7) | -- | -- | −4.85 (−7.88, .1–81) | −1.36 (−2.32, −0.48) |
| Baseline | 4.84 (2.34, 7.35) | 3.44 (1.01, 5.88) | -- | -- |
| Follow-up | 3.11 (1.35, 4.86) | 6.56 (2.75, 10.36) | -- | -- |
This is the difference of IE versus LHT on change score (follow-up minus baseline on study measures) where positive difference means indicate scores in the IE group increased more on this measure than in the LHT group.